Suppr超能文献

全球肝病负担:2023 年更新。

Global burden of liver disease: 2023 update.

机构信息

Department of Gastroenterology and Hepatology, St. John's Medical College Hospital, Bangalore, India.

Baylor University Medical Center, Baylor Scott and White, Dallas, TX, United States.

出版信息

J Hepatol. 2023 Aug;79(2):516-537. doi: 10.1016/j.jhep.2023.03.017. Epub 2023 Mar 27.

Abstract

Liver disease accounts for two million deaths annually and is responsible for 4% of all deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related deaths occur in men. Deaths are largely attributable to complications of cirrhosis and hepatocellular carcinoma, with acute hepatitis accounting for a smaller proportion of deaths. The most common causes of cirrhosis worldwide are related to viral hepatitis, alcohol, and non-alcoholic fatty liver disease. Hepatotropic viruses are the aetiological factor in most cases of acute hepatitis, but drug-induced liver injury increasingly accounts for a significant proportion of cases. This iteration of the global burden of liver disease is an update of the 2019 version and focuses mainly on areas where significant new information is available like alcohol-associated liver disease, non-alcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma. We also devote a separate section to the burden of liver disease in Africa, an area of the world typically neglected in such documents.

摘要

全球每年有 200 万人因肝脏疾病死亡,占所有死亡人数的 4%(全球每 25 人死亡中就有 1 人死于肝脏疾病);大约三分之二的与肝脏相关的死亡发生在男性中。死亡主要归因于肝硬化和肝细胞癌的并发症,急性肝炎导致的死亡比例较小。全球肝硬化最常见的原因与病毒性肝炎、酒精和非酒精性脂肪性肝病有关。嗜肝病毒是大多数急性肝炎病例的病因,但药物性肝损伤越来越占很大比例。本次全球肝脏疾病负担的更新版本是对 2019 年版本的更新,主要侧重于有大量新信息的领域,如酒精相关性肝病、非酒精性脂肪性肝病、病毒性肝炎和肝细胞癌。我们还专门用一个部分来介绍非洲的肝脏疾病负担,这是此类文件通常忽略的世界区域。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验